Literature DB >> 11953440

The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization.

Wendy M Barendt1, Stephen H Wright.   

Abstract

The organic cation transporter, OCT2, plays a role in renal secretion of a broad array of weak bases. To determine whether the degree of ionization of these compounds plays a role in their interaction with OCT2, we examined the influence of external pH values on the activity of the human ortholog of OCT2, as expressed in Chinese hamster ovary-K1 cells. Importantly, changing the pH value from 7.0 to 8.0 had no effect on the rate of transport of the fixed cations, tetraethylammonium and 1-methyl-4-phenylpyridinium, i.e. the pH value did not have an effect upon the transporter itself. Cimetidine (pK(a) 6.92), a competitive inhibitor of hOCT2, displayed a 3.5-fold increase in IC(50) as pH values increased from 7 to 8. hOCT2-mediated cimetidine transport decreased over this pH range, the consequence of an increase in K(t) and decrease in J(max) at the higher pH value. The weak bases trimethoprim and 4-phenylpyridine showed a similar pattern of pH-sensitive interaction with hOCT2. The non-ionizable sterol, corticosterone, also inhibited hOCT2 activity, although it was neither competitive in nature nor was it sensitive to pH in the manner observed with weak bases. We conclude that the degree of ionization plays a critical role in binding of substrate to organic cation transporters.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953440     DOI: 10.1074/jbc.M203114200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Pharmacological characteristics of the specific transporter for the endogenous cell growth inhibitor agmatine in six tumor cell lines.

Authors:  A Heinen; M Brüss; H Bönisch; M Göthert; G J Molderings
Journal:  Int J Colorectal Dis       Date:  2003-02-20       Impact factor: 2.571

Review 2.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Pharmacokinetic interaction of enrofloxacin/trimethoprim combination following single-dose intraperitoneal and oral administration in rats.

Authors:  Myung-Jin Choi; Sileshi Belew Yohannes; Seung-Jin Lee; Dereje Damte; Jong-Choon Kim; Joo-Won Suh; Seung-Chun Park
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-06-08       Impact factor: 2.441

4.  Organic cation uptake is enhanced in bcrp1-transfected MDCKII cells.

Authors:  Guoyu Pan; Tate N Winter; John C Roberts; Carolyn A Fairbanks; William F Elmquist
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

5.  OCT2 and MATE1 provide bidirectional agmatine transport.

Authors:  Tate N Winter; William F Elmquist; Carolyn A Fairbanks
Journal:  Mol Pharm       Date:  2010-12-03       Impact factor: 4.939

6.  Renal excretion of apricitabine in rats: ex vivo and in vivo studies.

Authors:  Mariana Babayeva; Susan Cox; Michael P White; David R Taft
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-04-06       Impact factor: 2.441

7.  Substrate specificity and mechanism of the intestinal clonidine uptake by Caco-2 cells.

Authors:  Wiebke Fischer; Linda Metzner; Kathrin Hoffmann; Reinhard H H Neubert; Matthias Brandsch
Journal:  Pharm Res       Date:  2006-12-13       Impact factor: 4.200

8.  LAPTM4A interacts with hOCT2 and regulates its endocytotic recruitment.

Authors:  A Grabner; S Brast; S Sucic; S Bierer; B Hirsch; H Pavenstädt; H H Sitte; E Schlatter; G Ciarimboli
Journal:  Cell Mol Life Sci       Date:  2011-05-08       Impact factor: 9.261

9.  Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2.

Authors:  Jaclyn N Harper; Stephen H Wright
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-03

Review 10.  The plasma membrane monoamine transporter (PMAT): Structure, function, and role in organic cation disposition.

Authors:  J Wang
Journal:  Clin Pharmacol Ther       Date:  2016-09-19       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.